^
Association details:
Biomarker:No biomarker
Cancer:Neuroendocrine Tumor
Regimen:FOLFIRINOX (5-fluorouracil + irinotecan + leucovorin calcium + oxaliplatin)
Direction:Sensitive
Evidence:
Evidence Level:
Sensitive: A2 - Guideline
New
Source:
Excerpt:
Poorly Differentiated Neuroendocrine Carcinoma/Large or Small Cell (Extrapulmonary): Locoregional Unresectable/Metastatic Disease:...FOLFIRINOX.